Product Categories
| Country: | China |
|---|---|
| Tel: | 0714-5316360 |
| Mobile: | 13165688766 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Clavulanate Potassium EP Impurity L | C8H20N2 | 4013-94-9 | Details |
| Clindamycin Impurity 4 | C34H63ClN2O6S | 68225-59-2 | Details |
| Canagliflozin Impurity 1 | C24H26O5S | 842133-16-8 | Details |
| Celecoxib Impurity 12 | C17H12F3N3O4S | 170571-01-4 | Details |
| Celecoxib Impurity 19 | C11H9F3O2 | 910303-54-7 | Details |
| Celecoxib Impurity 10 | C11H9F3N2 | 219986-64-8 | Details |
| Cabozantinib Impurity 13 | C17H14N2O5 | 202917-05-3 | Details |
| Canagliflozin Impurity 12 | C10H7FS | 119492-73-8 | Details |
| Celecoxib Impurity 16 | C12H13N5O4S2 | 4392-39-6 | Details |
| Celecoxib Impurity 13 | C6H8N2O3S | 877-67-8 | Details |
| Clindamycin EP Impurity B | C17H31ClN2O5S | 18323-43-8 | Details |
| Clindamycin Impurity 20 | C9H18ClNO4S | 22965-79-3 | Details |
| Celecoxib EP Impurity B | C17H14F3N3O2S | 331943-04-5 | Details |
| Clindamycin Impurity 5 | C35H65ClN2O6S | 1123211-69-7 | Details |
| Cabozantinib Impurity 14 | C10H10FNO | 2354-89-4 | Details |
| Canagliflozin Impurity 6 | C10H7FS | 58861-48-6 | Details |
| Clindamycin Phosphate EP Impurity J | C18H32ClN2O8PS | 1309349-64-1 | Details |
| Celecoxib Impurity 5 | C17H16F3N3O3S | 1803258-57-2 | Details |
| Celecoxib Impurity 25 | C17H12F3N3O3S | 2055787-31-8 | Details |
| Celecoxib Impurity 11 | C6H6ClN3O2S | 35282-78-1 | Details |
| Cabozantinib Impurity 10 | C11H10ClNO3 | 113136-79-1 | Details |
| Cabozantinib Impurity 2 | C11H10FNO3 | 918642-61-2 | Details |
| Celecoxib Impurity 15 | C6H6N2O | 36966-84-4 | Details |
| Celecoxib Impurity 30 | C11H9F3O2 | 53764-99-1 | Details |
| Clavulanate Potassium EP Impurity A | C8H12N2O2 | 4744-51-8 | Details |
| Clavulanate Potassium EP Impurity F | C13H14N2O5 | 1260857-16-6 | Details |
| Celecoxib EP Impurity A | C17H14F3N3O2S | 170570-01-1 | Details |
| Clindamycin Impurity 12 | C18H34ClN2O9PS | 1228573-90-7 | Details |
| Cabozantinib Impurity 1 | C11H11NO3 | 145591-80-6 | Details |
| Celecoxib Impurity C | C17H14F3N3O2S | 170569-99-0 | Details |
| Canagliflozin Impurity 2 | C24H25FO5S | 1589590-87-3 | Details |
| Clindamycin Impurity 2 | C18H32N2O5S | 198080-64-7 | Details |
| Clarithromycin Impurity 2 | C39H72N2O13 | 107216-09-1 | Details |
| Clindamycin Impurity 15 | C18H33ClN2O5S | 16684-06-3 | Details |
| Candesartan Cilexetil EP Impurity F | C35H38N6O6 | 914613-36-8 | Details |
| Clavulanate Potassium EP Impurity B | C11H16N2O4 | 96681-85-5 | Details |
| Clindamycin Impurity 3 | C33H61ClN2O6S | 68206-99-5 | Details |
| Clindamycin Impurity 8 | C33H61ClN2O6S | 1123211-67-5 | Details |
| Canagliflozin Impurity 4 | C24H25FO6S | 1672658-93-3 | Details |
| Cabozantinib Impurity 8 | C10H13NO3 | 1071574-51-0 | Details |
| Canagliflozin Impurity 9 | C6H10O6 | 52153-09-0 | Details |
| Clavulanate Potassium EP Impurity M | C8H20N2O | 3033-62-3 | Details |
| Canagliflozin Impurity 13 | C18H14BrFS | 2265214-89-7 | Details |
| Clindamycin Phosphate EP Impurity A | C18H34N2O6S | 154-21-2 | Details |
| Clindamycin Impurity 18 | C18H34ClN2O8PS | 1803042-32-1 | Details |
| Clavulanate Potassium EP Impurity G | C13H15NO6 | 374816-32-7 | Details |
| Celecoxib Impurity 17 | C11H9F3O2 | 163266-02-2 | Details |
| Candesartan Cilexetil EP Impurity E | C35H38N6O6 | 914613-35-7 | Details |
| Candesartan Cilexetil EP Impurity D | C33H34N6O6 | 1185256-03-4 | Details |
| Clindamycin Impurity 11 | C17H32ClN2O8PS | 54887-31-9 | Details |
| Celecoxib Impurity 9 | C15H17N3O2S | 1061214-06-9 | Details |
| Clindamycin Impurity 10 | C21H37ClN2O5S | 147650-54-2 | Details |
| Canagliflozin Impurity 11 | C10H7FS | 209592-45-0 | Details |
| Celecoxib Impurity 24 | C17H13F3N2O3S | 921617-76-7 | Details |
| Cabozantinib Impurity 11 | C17H15NO3 | 202916-99-2 | Details |
| Clindamycin Impurity 17 | C17H32Cl2N2O5S | 25532-03-0 | Details |
| Clindamycin Phosphate EP Impurity D | C18H34ClN2O8PS | 54887-30-8 | Details |
| Clindamycin Impurity 16 | C18H33ClN2O7S | 887402-22-4 | Details |
| Celecoxib Impurity 3 | C10H14N2O3S | 41472-49-5 | Details |
| Canagliflozin Impurity 15 | C24H25FO5S | 2161394-94-9 | Details |
| Celecoxib Impurity 22 | C19H17F3N2O3S | 2247197-67-5 | Details |
| Cabozantinib Impurity 3 | C17H14F2N2O2 | 1431468-36-8 | Details |
| Celecoxib Impurity 1 | C11H9F3N2 | 948293-46-7 | Details |
| Clavulanate Potassium EP Impurity D | C7H9NO3 | 404839-11-8 | Details |
| Candesartan Cilexetil EP Impurity B | C31H30N6O6 | 869631-11-8 | Details |
| Clindamycin Impurity 9 | C36H67ClN2O6S | 1123211-70-0 | Details |
| Clindamycin Impurity 19 | C18H35N2O9PS | 1149764-21-5 | Details |
| Celecoxib Impurity 7 | C18H16F3N3O2S | 170570-09-9 | Details |
| Clindamycin Impurity 6 | C30H56Cl2N2O6S | 25507-13-5 | Details |
| Celecoxib Impurity 6 | C17H14F3N3O3S | 170571-00-3 | Details |
| Celecoxib Impurity 29 | C18H14F3N3O4S | 1189893-75-1 | Details |
| Clindamycin Impurity 7 | C18H33ClN2O6S | 22431-46-5 | Details |
| Clindamycin Phosphate EP Impurity L | C18H34ClN2O8PS | 620181-05-7 | Details |
| Clindamycin Phosphate EP Impurity C | C18H34ClN2O8PS | 28708-34-1 | Details |
| O-Desethyl Candesartan | C22H16N6O3 | 168434-02-4 | Details |
| Celecoxib Impurity 20 | C17H15F3N2O3S | 1061214-09-2 | Details |
| Canagliflozin Impurity 8 | C24H25FO6S | 1951467-29-0 | Details |
| Celecoxib Impurity 21 | C19H16F3N3O3S | 198471-47-5 | Details |
| Celecoxib Impurity 23 | C18H15F3N2O3S | 2247197-66-4 | Details |
| Cabozantinib Impurity 12 | C17H14N2O5 | 190728-26-8 | Details |
| Canagliflozin Impurity 10 | C10H7FS | 58861-49-7 | Details |
| Celecoxib Impurity 4 | C16H12F3N3O2S | 170569-87-6 | Details |
| Clavulanate Potassium EP Impurity E | C16H18N2O10 | 1260617-10-4 | Details |
| Celecoxib Impurity 28 | C17H13BrF3N3O2S | 170570-75-9 | Details |
| Candesartan Cilexetil Impurity 1 | C52H48N6O6 | 886999-34-4 | Details |
| Clindamycin Impurity 14 | C18H31ClN2O5S | 1440605-51-5 | Details |
| Canagliflozin Impurity 7 | C24H23FO6S | 1951467-28-9 | Details |
| Celecoxib Impurity 14 | C6H7N3O3S | 343853-74-7 | Details |
| Cabozantinib Impurity 9 | C11H10FNO3 | 1247859-37-5 | Details |
| Cabozantinib Impurity 7 | C17H15FN2O3 | 849217-60-3 | Details |
| Candesartan Cilexetil EP Impurity C | C33H34N6O6 | 1185255-99-5 | Details |
| Celecoxib Impurity 27 | C18H16F3N3O2S | 457639-26-8 | Details |
| Clavulanate Potassium EP Impurity C | C10H16N2O2 | 86917-74-0 | Details |
| Celecoxib Impurity 2 | C23H20F3N3O10S | 264236-79-5 | Details |
| N-Cilexetil Candesartan Ethyl Ester | C35H38N6O6 | 1391054-45-7 | Details |
| Clindamycin Phosphate EP Impurity F | C18H35N2O9PS | 27480-30-4 | Details |
| Celecoxib Impurity 8 | C8H8F3N3O3S | 915280-81-8 | Details |
| Clindamycin Impurity 13 | C37H67ClN2O6S | 906126-31-6 | Details |
| Celecoxib Impurity 26 | C17H14F3N3O3S | 2356153-95-0 | Details |
| Cabozantinib Impurity 5 | C11H10ClNO3 | 2377278-36-7 | Details |
| Product Total： Product Page： | ||||
| 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 | ||||